Elanco Animal Health Research and Development Expenses 2016-2026 | ELAN
Elanco Animal Health annual/quarterly research and development expenses history and growth rate from 2016 to 2026. Research and development expenses can be defined as an expense arising from studies and product development processes.
- Elanco Animal Health research and development expenses for the quarter ending March 31, 2026 were $97M, a 3.19% increase year-over-year.
- Elanco Animal Health research and development expenses for the twelve months ending March 31, 2026 were $371M, a 5.7% increase year-over-year.
- Elanco Animal Health annual research and development expenses for 2025 were $0.368B, a 6.98% increase from 2024.
- Elanco Animal Health annual research and development expenses for 2024 were $0.344B, a 5.2% increase from 2023.
- Elanco Animal Health annual research and development expenses for 2023 were $0.327B, a 1.87% increase from 2022.
|
Elanco Animal Health Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2025 | $368 |
| 2024 | $344 |
| 2023 | $327 |
| 2022 | $321 |
| 2021 | $369 |
| 2020 | $329 |
| 2019 | $270 |
| 2018 | $247 |
| 2017 | $252 |
| 2016 | $266 |
| 2015 | $291 |
|
Elanco Animal Health Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2026-03-31 | $97 |
| 2025-12-31 | $93 |
| 2025-09-30 | $89 |
| 2025-06-30 | $92 |
| 2025-03-31 | $94 |
| 2024-12-31 | $81 |
| 2024-09-30 | $87 |
| 2024-06-30 | $89 |
| 2024-03-31 | $87 |
| 2023-12-31 | $79 |
| 2023-09-30 | $86 |
| 2023-06-30 | $81 |
| 2023-03-31 | $81 |
| 2022-12-31 | $80 |
| 2022-09-30 | $78 |
| 2022-06-30 | $82 |
| 2022-03-31 | $81 |
| 2021-12-31 | $92 |
| 2021-09-30 | $94 |
| 2021-06-30 | $94 |
| 2021-03-31 | $89 |
| 2020-12-31 | $115 |
| 2020-09-30 | $88 |
| 2020-06-30 | $59 |
| 2020-03-31 | $67 |
| 2019-12-31 | $67 |
| 2019-09-30 | $70 |
| 2019-06-30 | $69 |
| 2019-03-31 | $64 |
| 2018-12-31 | $61 |
| 2018-09-30 | $59 |
| 2018-06-30 | $61 |
| 2018-03-31 | $65 |
| 2017-12-31 | |
| 2017-09-30 | $62 |
| 2016-12-31 | |
| 2015-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $11.500B | $4.715B |
| Elanco Animal Health Incorporated operates as an animal health care company. It develops, manufactures and markets products for companion and food animals. Elanco Animal Health Incorporated is based in Greenfield, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.514B | 13.37 |
| Quest Diagnostics (DGX) | United States | $21.197B | 19.44 |
| Encompass Health (EHC) | United States | $10.662B | 19.64 |
| DaVita (DVA) | United States | $10.023B | 13.82 |
| Chemed (CHE) | United States | $5.639B | 19.57 |
| Option Care Health (OPCH) | United States | $4.553B | 18.71 |
| RadNet (RDNT) | United States | $4.302B | 142.13 |
| LifeStance Health (LFST) | United States | $2.495B | 320.00 |
| Addus HomeCare (ADUS) | United States | $1.719B | 16.61 |
| Astrana Health (ASTH) | United States | $1.536B | 31.40 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.353B | 12.20 |
| U.S Physical Therapy (USPH) | United States | $1.157B | 29.19 |
| Pennant (PNTG) | United States | $1.072B | 31.31 |
| Daxor (DXR) | United States | $0.048B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.032B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |